Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients-Reference-Cited by-同舟云学术

Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients

Published:2018-04-17 Issue:11 Volume:18 Page:2752-2762
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Lorant Tomas¹,Bengtsson Mats²,Eich Torsten²^ORCID,Eriksson Britt-Marie³^ORCID,Winstedt Lena⁴,Järnum Sofia⁴,Stenberg Yvonne⁴,Robertson Anna-Karin⁴^ORCID,Mosén Kristina⁴,Björck Lars⁵^ORCID,Bäckman Lars¹,Larsson Erik⁶,Wood Kathryn⁷,Tufveson Gunnar¹,Kjellman Christian⁴

Affiliation:

1. Department of Surgical Sciences; Section of Transplantation Surgery; Uppsala University; Uppsala Sweden

2. Department of Immunology, Genetics and Pathology; Section of Clinical Immunology; Uppsala University; Uppsala Sweden

3. Department of Medical Sciences; Section of Infectious Diseases; Uppsala University; Uppsala Sweden

4. Hansa Medical AB; Lund Sweden

5. Department of Clinical Sciences; Division of Infection Medicine; Lund University; Lund Sweden

6. Department of Immunology, Genetics and Pathology; Section of Molecular and Morphological Pathology; Uppsala University; Uppsala Sweden

7. Nuffield Department of Surgical Sciences; Oxford University; Oxford UK

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14733/fullpdf

Reference21 articles.

1. Significance of the positive crossmatch test in kidney transplantation;Patel;N Engl J Med,1969

2. Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation;Higgins;The Lancet,1996

3. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg);Glotz;Am J Transplant,2002

4. Desensitization in HLA-Incompatible Kidney Recipients and Survival;Montgomery;N Engl J Med,2011

5. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody;Stegall;Am J Transplant,2006

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Versatile conductometric biosensors for rapid and selective detection of inflammatory and cardiac biomarkers in saliva;Biosensors and Bioelectronics;2024-10

2. The potential for therapeutic drug monitoring of belatacept and other biologicals in solid organ transplantation;British Journal of Clinical Pharmacology;2024-07-26

3. New Therapies for Highly Sensitized Patients on the Waiting List;Kidney360;2024-07-12

4. A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody‐Mediated Rejection;Clinical Transplantation;2024-07

5. Imlifidase in Highly Sensitized Kidney Transplant Recipients With a Positive Crossmatch Against a Deceased Donor;Kidney International Reports;2024-07